Everyday Chemical Mixtures May Reshape Breast Tissue Development, Study Finds

Common chemicals encountered in daily life may leave lasting molecular fingerprints on developing human breast tissue, according to a new study from researchers at Tufts University School of Medicine and Boston University. The research, published in the Proceedings of the National Academy of Sciences, suggests that exposure to certain endocrine-disrupting compounds—particularly when several bisphenols act together—can alter the developmental trajectory of normal breast tissue in ways that could, in principle, influence susceptibility to breast disease later in life. The work does not prove that these chemicals cause cancer, but it offers something arguably just as valuable: a laboratory platform for investigating how environmental exposures might reprogram human tissue before any disease appears, and a potential route to biomarkers that could one day help identify people at elevated risk of breast cancer.

What sets this study apart from much of the existing toxicology literature is the model system. Scientists have long suspected a link between so-called endocrine-disrupting chemicals and breast cancer risk, but most of that evidence has come from animal models or from flat layers of laboratory-grown cells that fail to capture the architecture and behavior of genuine human tissue. The breast is an unusual organ in this respect. Unlike most structures in the body, it undergoes major developmental remodeling long after birth, most dramatically during puberty and pregnancy. Charlotte Kuperwasser, the study’s senior author and a professor of developmental, molecular, and chemical biology at Tufts University School of Medicine, emphasized that this extended developmental window is precisely what makes the breast potentially vulnerable. Breast tissue cells, she noted, may be highly sensitive to environmental cues such as chemical exposure during these critical periods of mammary gland development.

To approximate that complexity in the laboratory, the team turned to three-dimensional models known as organoids, grown from breast tissue donated by 13 healthy young women. Organoids are miniature, self-organizing tissue cultures that contain multiple cell types found in the native organ. In this case, the breast organoids reproduced key aspects of how human breast tissue actually develops, branching and maturing in a way that standard two-dimensional cell cultures simply cannot. This meant the researchers could watch, in real time and at molecular resolution, what happens when developing human breast tissue encounters chemicals at concentrations people actually experience.

Over roughly three weeks of development, the organoids were exposed to a panel of individual chemicals and chemical mixtures. The selection was deliberately broad, encompassing endocrine-disrupting chemicals that interfere with hormones, compounds that affect cellular metabolism, and agents known or suspected to cause cancer. After exposure, the researchers analyzed molecular changes across the tissue, including shifts in gene activity and alterations in DNA modifications—epigenetic marks that regulate which genes are switched on or off without changing the underlying genetic sequence. The results showed that different chemicals affected tissue development in different ways, but the most consequential finding involved three structurally related compounds: bisphenol A (BPA), bisphenol S (BPS), and bisphenol F (BPF).

BPA is the notorious veteran of this family, widely known as a component of certain plastics and food-can linings. BPS and BPF are the chemical cousins that industry increasingly adopted as BPA came under regulatory and consumer scrutiny. Individually, at the doses tested, each of the three bisphenols produced relatively few changes in the developing organoids. The surprise came when the researchers combined them. Applied together at very low concentrations—levels comparable to those actually detected in human blood and urine—the bisphenol mixture disrupted normal breast development in organoids derived from most of the donors. This convergence matters because real-world human exposure rarely involves a single compound in isolation. Kuperwasser explained that the team intentionally used concentrations relevant to real-world exposure rather than the very high doses sometimes deployed in toxicology studies, and tested mixtures precisely because people are typically exposed to multiple chemicals simultaneously.

The next step pushed the findings into territory with direct clinical resonance. The researchers compared the molecular signature induced by the bisphenol mixture with molecular data from human breast cancers. The exposure-associated pattern aligned most strongly with data from patients diagnosed with invasive lobular carcinoma, a subtype of breast cancer with a distinctive character. Lobular carcinomas arise in the lobules of the breast and often grow in diffuse patterns that do not form a detectable lump, making them notoriously difficult to catch with standard mammography. It is important to stress what this comparison does and does not demonstrate. It does not establish that bisphenols cause lobular cancer, nor does it explain the mechanism by which the observed molecular changes might contribute to disease. What it shows is a suggestive overlap: tissue reprogrammed by low-dose chemical mixtures in the laboratory bears epigenetic resemblance to a cancer subtype that is hard to detect and understudied.

The conceptual leap the authors propose is a rethinking of how environmental exposures fit into cancer risk. Historically, Kuperwasser observed, cancer risk has been framed largely in terms of inherited mutations, lifestyle factors, and exposures that directly damage DNA, such as radiation or tobacco carcinogens. These findings raise another possibility: environmental exposures may subtly alter how normal tissues develop, leaving behind molecular changes that do not cause cancer on their own but may render the tissue more permissive to malignant transformation many years later. In this framing, the relevant harm is not genotoxic damage but a kind of developmental detour—epigenetic rewiring that persists quietly in otherwise healthy tissue and lowers the barriers that a future initiating event would need to overcome.

That persistence points toward a practical application. If the molecular alterations induced by chemical exposure survive in human tissues over time, they could function as a biological record of past exposure—a scar written in epigenetic marks. Kuperwasser suggested that if such markers are validated in people, they could potentially help identify individuals at higher risk of breast cancer and inform earlier or more targeted screening strategies. For a disease in which early detection dramatically improves outcomes, and in which risk assessment currently relies heavily on family history and genetic variants that explain only a fraction of cases, a biomarker reflecting cumulative environmental exposure would fill a genuine gap in preventive medicine.

Substantial caveats remain, and the researchers are explicit about them. The organoids came from 13 donors, a sample size that cannot capture the full genetic and developmental diversity of the population, and the study involved a limited panel of chemicals and mixtures. The field will need larger and more diverse cohorts of tissue donors, a wider range of chemical exposures, and longitudinal studies to determine how broadly the findings apply and whether the molecular changes observed in organoids correlate with actual breast disease in people. Validation in human populations is the essential next step before any clinical translation. Still, the study establishes a methodological foundation: a human-relevant, three-dimensional system in which the long-suspected effects of everyday chemical mixtures on breast development can finally be observed and quantified.

The research was led by co-first authors Meadow Parrish and Meloryn Seraj, both PhD students in genetics, molecular, and cellular biology at Tufts Graduate School of Biomedical Sciences, and was supported by the Find The Cause Breast Cancer Foundation. The authors declare no competing interests. If the results hold up under further scrutiny, they could change how scientists and public health authorities think about cancer prevention—shifting attention from purely genetic and lifestyle determinants toward the cumulative, low-dose chemical environment that surrounds human development from puberty onward. For now, the study stands as a technical achievement with an urgent message: the chemistry of everyday life may be writing itself into the biology of human tissue, and for the first time, researchers have a tool capable of reading it.

Subject of Research: How endocrine-disrupting chemical mixtures alter normal human breast tissue development and may shape breast cancer risk.

Article Title: Study finds common chemicals may alter normal breast development

Article References: Study finds common chemicals may alter normal breast development. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: bisphenols, BPA, endocrine-disrupting chemicals, breast cancer, organoids, epigenetics, mammary gland development, invasive lobular carcinoma, chemical mixtures, Tufts University, PNAS, toxicology